27.09.2011 • NewsJean-Pierre GarnierActelionPeople

Jean-Pierre Garnier Elected as Chairman of Actelion's Board of Directors

Actelion announced that Jean-Pierre Garnier has become Chairman of the Board of Directors of the Swiss biopharmaceutical company. The Board of Directors elected him at their meeting today, 27 September 2011. In order to ensure a smooth transition, Robert Cawthorn, who has been Chairman since the inception of the company, will stay on the Board as planned until the 2012 Annual General Meeting.

Since joining the Board, Jean-Pierre has been very active in talking to Actelion's key people and understanding the company's opportunities and challenges. We are now entering a new planning cycle and he will be able to oversee this process and its implementation as Chairman from the start."

Dr. Jean-Pierre Garnier said: "I am extremely proud to have been nominated as Chairman of the Board of Actelion. I'm very impressed with the company's track record and its position today as Europe's largest biopharmaceutical company. Since joining the company this spring, I have become even more convinced of Actelion's capacity to translate superior drug discovery into meaningful therapeutic solutions and long-term business success. I look forward to guiding the company in the next phase of its growth together with my fellow Board members, management and all the Actelion employees."

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.